This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Reply to Letter to Editor from Veeravalli and Dash on “Tofacitinib Is a Mechanism-Based Inactivator of Cytochrome P450 3A4: Revisiting the Significance of the Epoxide Intermediate and Glutathione Trapping”, Chemical Research in Toxicology, May 2020, American Chemical Society (ACS),
DOI: 10.1021/acs.chemrestox.0c00187.
You can read the full text:
The following have contributed to this page
